December 25, 2017 / 8:56 AM / 5 months ago

BRIEF-Easywell Biomedicals unit completes phase I clinical trial of TWB-103

Dec 25(Reuters) - Easywell Biomedicals Inc

* Says its biotech unit completes phase I clinical trial of TWB-103, a fetal skin cells wound dressing, and will start phase II clinical trial in Taiwan and Japan

Source text in Chinese: goo.gl/5w7hRa

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below